Interest in microbiota has reached all areas of human health and disease. As a result, the therapeutic potential of probiotics has expanded. 2013 saw a surge of investment into prebiotics and probiotics, coinciding with an increase in microbiome funding. In the last decade, investment has quadrupled.
Attune Foods, KeVita and Evolve Biosystems are prominent companies exploring functional foods, drinks and therapeutics. Of the 70+ investors exploring prebiotics and probiotics, the most active are Indiebio, Maveron and BioGaia.
Find Out More: Global Engage